
Hepatitis B Vaccine Study in Africa Halted After Controversy
Hepatitis B Vaccine Study in Africa Halted After Controversy
A US-funded study in Guinea-Bissau investigating hepatitis B vaccines in newborns has been cancelled due to ethical concerns regarding the withholding of proven preventative vaccines in a high-risk population. Experts raised concerns about the study's design, emphasizing the need for ethical research practices when evaluating public health interventions, especially in vulnerable communities. The cancellation highlights the importance of adhering to established medical norms and prioritizing proven preventative measures in regions with high disease burdens.




























